Total Payments
$1,223
2024 Payments
$382.12
Companies
11
Transactions
84
Medicare Patients
5,124
Medicare Billing
$533,271
Payment Breakdown by Category
Food & Beverage$1,223 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,223 | 84 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $638.23 | 47 | $0 (2024) |
| Medtronic, Inc. | $247.18 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $144.55 | 21 | $0 (2019) |
| Phathom Pharmaceuticals, Inc. | $50.06 | 3 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $45.43 | 3 | $0 (2018) |
| Gilead Sciences, Inc. | $22.40 | 1 | $0 (2024) |
| Madrigal Pharmaceuticals | $19.51 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $15.47 | 1 | $0 (2024) |
| Nestle HealthCare Nutrition Inc. | $15.07 | 1 | $0 (2022) |
| AIMMUNE THERAPEUTICS, INC. | $14.11 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $382.12 | 21 | ABBVIE INC. ($160.99) |
| 2023 | $280.28 | 14 | AbbVie Inc. ($146.77) |
| 2022 | $28.50 | 2 | Nestle HealthCare Nutrition Inc. ($15.07) |
| 2021 | $129.55 | 11 | AbbVie Inc. ($115.46) |
| 2020 | $22.27 | 1 | AbbVie Inc. ($22.27) |
| 2019 | $133.03 | 10 | AbbVie, Inc. ($84.77) |
| 2018 | $227.54 | 24 | Takeda Pharmaceuticals U.S.A., Inc. ($96.29) |
| 2017 | $19.53 | 1 | AbbVie, Inc. ($19.53) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Medtronic, Inc. | ENDOFLIP (Device) | Food and Beverage | In-kind items and services | $99.58 | General |
| Category: Motility Testing | ||||||
| 11/13/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: LIVER DISEASE | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/14/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: VIROLOGY | ||||||
| 07/29/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.07 | General |
| Category: IMMUNOLOGY | ||||||
| 06/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/14/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: VIROLOGY | ||||||
| 05/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: IMMUNOLOGY | ||||||
| 05/02/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/23/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Immunology | ||||||
| 03/19/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: VIROLOGY | ||||||
| 03/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.40 | General |
| 03/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.54 | General |
| Category: IMMUNOLOGY | ||||||
| 02/06/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: VIROLOGY | ||||||
| 12/12/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: VIROLOGY | ||||||
| 12/07/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2023 | Medtronic, Inc. | HET (Device) | Food and Beverage | In-kind items and services | $0.57 | General |
| Category: Electrosurgical Products | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 838 | 1,019 | $599,430 | $99,720 |
| 2022 | 15 | 1,025 | 1,212 | $671,961 | $111,221 |
| 2021 | 18 | 1,145 | 1,329 | $649,236 | $129,869 |
| 2020 | 23 | 2,116 | 2,502 | $474,177 | $192,460 |
Total Patients
5,124
Total Services
6,062
Medicare Billing
$533,271
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 170 | 170 | $255,000 | $34,651 | 13.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 104 | 145 | $23,200 | $8,841 | 38.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 49 | 49 | $38,220 | $8,369 | 21.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 80 | 87 | $26,796 | $7,859 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 82 | $19,516 | $7,250 | 37.2% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 53 | 58 | $30,160 | $5,629 | 18.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 33 | 33 | $25,773 | $5,544 | 21.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 86 | 91 | $56,875 | $3,935 | 6.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 45 | 96 | $9,888 | $3,509 | 35.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 49 | 51 | $67,932 | $3,280 | 4.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 13 | 61 | $7,625 | $2,965 | 38.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $9,855 | $2,920 | 29.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 37 | 37 | $20,942 | $2,567 | 12.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $7,648 | $2,400 | 31.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 172 | 172 | $258,000 | $32,806 | 12.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 139 | 230 | $36,800 | $14,510 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 124 | $29,512 | $11,355 | 38.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 81 | 88 | $27,104 | $8,467 | 31.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 35 | 35 | $27,300 | $6,040 | 22.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 47 | 47 | $17,155 | $5,605 | 32.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 31 | 31 | $24,211 | $5,474 | 22.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 50 | 50 | $26,000 | $5,063 | 19.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 92 | 95 | $59,375 | $4,784 | 8.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 59 | 59 | $14,101 | $4,315 | 30.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 58 | 113 | $11,639 | $3,201 | 27.5% |
About Jay Takata
Jay Takata is a Gastroenterology healthcare provider based in Athens, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1083801518.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jay Takata has received a total of $1,223 in payments from pharmaceutical and medical device companies, with $382.12 received in 2024. These payments were reported across 84 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,223).
As a Medicare-enrolled provider, Takata has provided services to 5,124 Medicare beneficiaries, totaling 6,062 services with total Medicare billing of $533,271. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Athens, TX
- Active Since 09/28/2007
- Last Updated 07/06/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1083801518
Products in Payments
- RINVOQ (Biological) $200.79
- Amitiza (Drug) $144.55
- MAVYRET (Drug) $135.42
- MANOSCAN (Device) $132.94
- ENDOFLIP (Device) $99.58
- VOQUEZNA (Drug) $50.06
- Trulance (Drug) $45.43
- CREON (Drug) $44.38
- ZENPEP (Drug) $29.18
- HUMIRA (Biological) $28.96
- SKYRIZI (Biological) $27.10
- RESMETIROM (Drug) $19.51
- STELARA (Biological) $15.47
- Creon (Drug) $14.62
- PillCam (Device) $14.09
- Sucraid (Drug) $10.81
- HET (Device) $0.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Athens
Jeffrey Williams, Md, MD
Gastroenterology — Payments: $265,211
Gastroenterology $265,211
Dr. Gregory Smith, Medical Doctor, MEDICAL DOCTOR
Gastroenterology — Payments: $32,655
Gastroenterology $32,655
Minesh Mehta, M.d, M.D
Gastroenterology — Payments: $32,439
Gastroenterology $32,439
Kelly Grow, Md, MD
Gastroenterology — Payments: $12,213
Gastroenterology $12,213
Dr. Brian Torski, D.o, D.O
Gastroenterology — Payments: $3,745
Gastroenterology $3,745
Srikar Mapakshi, M.d, M.D
Gastroenterology — Payments: $3,441
Gastroenterology $3,441